Canada’s largest special purpose acquisition company (SPAC) has debuted on the NEO Exchange.

On Tuesday (July 16), NEO announced that Subversive Capital Acquisition’s (NEO:SVC.UN.U) Class A restricted voting units are now available to investors.


Subversive’s initial public offering (IPO) of US$575 million made it the largest SPAC IPO in Canadian history, according to a press release. Following its qualifying transaction, Subersive’s strategy will be to “identify, acquire and … assist in the growth of a business in the cannabis industry.”

The newly organized SPAC will be the fifth one to list on the NEO and will focus its efforts on targeting businesses that are in the cannabis industry and related sectors. 

SPACs are publicly traded companies that seek capital from investors through an IPO for the purpose of acquiring an existing company. The capital raised through the IPO is put into a trust until the SPAC identifies an acquisition or merger it plans to pursue with the funds. Along with other restrictions, SPACs have a certain period of time usually 24 months within which they must complete the acquisition.

In the same press release, Leland Hensch, CEO and director at Subversive, said the company is “very excited to be listing with the leader in SPACs in Canada.”

In an interview with the Investing News Network, NEO CEO Jos Schmitt said that the size of Subversive’s IPO is an indicator that investors see “tremendous potential” in the cannabis industry.

“We’re looking at what is the largest, regardless of industry or sector … SPAC that’s ever been listed in Canada, and I think that is a token about the interest and appetite in this industry and the opportunity it represents,” said Schmitt.

He added that the cannabis sector’s relatively young age makes it a great space for SPACs, saying they are “the right vehicle, at the right moment, in the right industry.” 

One of Subversive’s partners is Michael Auerbach, who also currently acts as director at Tilray (NASDAQ:TLRY), a medical cannabis company.

Subversive filed a preliminary prospectus for an IPO last month. Its target was initially to acquire an operating business with an enterprise value between US$750 million and US$5 billion.

As mentioned, Subversive isn’t the only cannabis-focused SPAC that has launched on the NEO this year. Others have flocked to the exchange to help establish themselves in the marijuana space.

AYR Strategies (NEO:AYR.A), a multi-state operator (MSO) in the US cannabis sector, began trading on the NEO earlier this year. Previously known as SPAC Cannabis Strategies Acquisition (CSA), AYR was the first recreational cannabis-focused company with an enterprise value over C$1 billion as well as the first SPAC to list on NEO. 

The company completed its IPO as a SPAC in December 2017, initially looking to raise C$125 million to buy private cannabis companies valued between C$150 million and C$300 million, according to an article in the Globe and Mail. As a part of its qualifying transaction, CSA acquired five different cannabis businesses in Nevada and Massachusetts.

In May, Mercer Park Brand Acquisition (NEO:BRND.A.U) also began trading on the Toronto-based stock exchange after closing an IPO of US$402.5 million of Class A restricted voting units. Currently, Mercer Park holds a market cap of over C$392 million.

In addition to the cannabis SPACs, the NEO lists Canaccord Genuity Growth II (NEO:CGGZ.UN), an active SPAC from banking firm Canaccord Genuity Group (TSX:CF). The financial institution completed a transaction to merge its first SPAC, Canaccord Genuity Growth, with Columbia Care (NEO:CCHW,CCHW.WT) as a way to transfer its listing to the MSO.

Subversive currently has a market cap of C$574.43 million and its share price closed at C$9.99 on its first day of trading. On Wednesday (July 17), its share price stood at C$10.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less